期刊
BIOORGANIC & MEDICINAL CHEMISTRY
卷 26, 期 10, 页码 2766-2773出版社
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.bmc.2017.08.031
关键词
Bioavailability; Cyclic peptides; N-Methylation; Peptide-based drugs; Caco-2; Peptidomimetics; Membrane transport; Cyclosporin A
资金
- CIPSM of the Deutsche Forschungsgemeinschaft
- Koselleck grant of the Deutsche Forschungsgemeinschaft [KE147/42-1]
The renaissance of peptides in pharmaceutical industry results from their importance in many biological functions. However, low metabolic stability and the lack of oral availability of most peptides is a certain limitation. Whereas metabolic instability may be often overcome by development of small cyclic peptides containing D-amino acids, the very low oral availability of most peptides is a serious limitation for some medicinal applications. The situation is complicated because a twofold optimization-biological activity and oral availability-is required to overcome this problem. Moreover, most simple rules for achieving oral availability are not general and are applicable only to limited cases. Many structural modifications for increasing biological activities and metabolic stabilities of cyclic peptides have been described, of which N-alkylation is probably the most common. This mini-review focuses on the effects of N-methylation of cyclic peptides in strategies to optimize bioavailabilities. (C) 2017 The Authors. Published by Elsevier Ltd.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据